PT Prodia Widyahusada Tbk (ISX:PRDA) Research & Development: Rp4,059 Mil (TTM As of Mar. 2026)


ISX:PRDA PT Prodia Widyahusada Tbk ISX:PRDA
77 GF Score
Price Rp2,500.00
GF Value Rp3,123.88
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is PT Prodia Widyahusada Tbk Research & Development?

PT Prodia Widyahusada Tbk ISX:PRDA +2.46% 77 Research & Development is Rp4,059 Mil as of Mar. 2026. GuruFocus rates ISX:PRDA with a GF Score™ of 77/100 and a GF Value™ of Rp3,123.88 (Modestly Undervalued). The stock has 2 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. PT Prodia Widyahusada Tbk's Research & Development for the three months ended in Mar. 2026 was Rp669 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was Rp4,059 Mil.

PT Prodia Widyahusada Tbk  (ISX:PRDA) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

PT Prodia Widyahusada Tbk Research & Development Related Terms

PT Prodia Widyahusada Tbk Research & Development Historical Data

* Premium members only.

The historical data trend for PT Prodia Widyahusada Tbk's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Prodia Widyahusada Tbk Research & Development Chart

PT Prodia Widyahusada Tbk Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,050.00 3,119.00 1,849.00 5,868.00 4,494.00

PT Prodia Widyahusada Tbk Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,104.00 2,098.00 321.00 971.00 669.00
ISX:PRDA
77GF Score
PT Prodia Widyahusada Tbk ISX:PRDA
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PT Prodia Widyahusada Tbk Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp4,059 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of Rp4,059 Mil mean?
PT Prodia Widyahusada Tbk (ISX:PRDA) has a Research & Development of Rp4,059 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on PT Prodia Widyahusada Tbk and its competitors.
Is PT Prodia Widyahusada Tbk's Research & Development too high?
PT Prodia Widyahusada Tbk's current Research & Development is Rp4,059 Mil. Overall, PT Prodia Widyahusada Tbk has a GF Score™ of 77/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Prodia Widyahusada Tbk's Research & Development compare to TMO and DHR?
PT Prodia Widyahusada Tbk's Research & Development of Rp4,059 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Diagnostics & Research company?
A good Research & Development depends on the Medical Diagnostics & Research industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on PT Prodia Widyahusada Tbk and its competitors. PT Prodia Widyahusada Tbk's current Research & Development is Rp4,059 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Prodia Widyahusada Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Prodia Widyahusada Tbk (ISX:PRDA) is currently considered Modestly Undervalued. The stock's GF Value™ is Rp3,123.88, compared to a current price of Rp2,500.00 — trading 20% below its estimated fair value. The current Research & Development is Rp4,059 Mil. PT Prodia Widyahusada Tbk's overall GF Score™ is 77/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For PT Prodia Widyahusada Tbk (ISX:PRDA), the current Research & Development is Rp4,059 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PT Prodia Widyahusada Tbk (ISX:PRDA) Overvalued in 2026?

Based on GuruFocus' analysis, PT Prodia Widyahusada Tbk stock appears to be undervalued. The current stock price of Rp2,500.00 is trading 20% below its estimated GF Value™ of Rp3,123.88. GuruFocus considers PT Prodia Widyahusada Tbk to be Modestly Undervalued.

Key valuation signals for ISX:PRDA:

  • Research & Development: Rp4,059 Mil
  • GF Value™: Rp3,123.88 vs. price of Rp2,500.00 (20% below fair value)
  • GF Score™: 77/100 with 2 warning signs

No single metric tells the full story. See the ISX:PRDA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PT Prodia Widyahusada Tbk Business Description

Address Jl. Kramat Raya No.150, Prodia Tower, Pusat, Jakarta, IDN, 10430
PT Prodia Widyahusada Tbk provides health care testing services. The company provides analytic and diagnostic services for the medical professionals. It is engaged in health laboratories by conducting business activities such as setting up clinics, health laboratories, management of hospitals, and health checkup services. Its operating segments are Central: Jakarta; Sumatera: Sumatera, Kepulauan Riau; Greater Jakarta: Jakarta, Bogor, Depok, Tangerang, Bekasi, Lampung, Pangkal Pinang; West Java; Central Java; East Java, Bali, Nusa Tenggara; Kalimantan Sulampua: Kalimantan, Sulawesi, Ambon, Papua.
77GF Score

Get the complete analysis for ISX:PRDA

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp2,500.00
Price
Rp3,123.88
GF Value